Defining the Risk of Early Recurrence Following Curative-Intent Resection for Distal Cholangiocarcinoma-Reference-Cited by-同舟云学术

Defining the Risk of Early Recurrence Following Curative-Intent Resection for Distal Cholangiocarcinoma

Published:2021-03-11 Issue:8 Volume:28 Page:4205-4213
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Sahara Kota,Tsilimigras Diamantis I.,Toyoda Junya,Miyake Kentaro,Ethun Cecilia G.,Maithel Shishir K.,Abbott Daniel E.,Poultsides George A.,Hatzaras Ioannis,Fields Ryan C.,Weiss Matthew,Scoggins Charles,Isom Chelsea A.,Idrees Kamran,Shen Perry,Yabushita Yasuhiro,Matsuyama Ryusei,Endo Itaru,Pawlik Timothy M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-021-09811-4.pdf

Reference45 articles.

1. Bridgewater JA, Goodman KA, Kalyan A, Mulcahy MF. Biliary tract cancer: epidemiology, radiotherapy, and molecular profiling. ASCO. 2016;36:e194–203.

2. Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–9.

3. Lopez-Aguiar AG, Ethun CG, Pawlik TM, et al. Association of Perioperative transfusion with recurrence and survival after resection of distal cholangiocarcinoma: a 10-institution study from the US extrahepatic biliary malignancy consortium. Ann Surg Oncol. 2019;26(6):1814–23.

4. Hatzaras I, George N, Muscarella P, et al. Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann Surg Oncol. 2010;17(4):991–7.

5. Edeline J, Benabdelghani M, Bertaut A, et al. Gemcitabine and Oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study. J Clin Oncol. 2019;37(8):658–67.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreaticoduodenectomy for distal cholangiocarcinoma at a South African centre;South African Journal of Surgery;2024-06

2. A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study;BMC Cancer;2024-04-08

3. Optimized early recurrence score for distal cholangiocarcinoma: A new attempt by adding imaging indicators;European Journal of Radiology;2024-02

4. Time to surgery is not an oncological risk factor in patients with cholangiocarcinoma undergoing curative-intent liver surgery;Scientific Reports;2024-01-18

5. Development and validation of web calculators to predict early recurrence and long-term survival in patients with duodenal papilla carcinoma after pancreaticoduodenectomy;BMC Cancer;2023-11-20